Supporting CKD Patients at Home - European Medical Journal

Supporting CKD Patients at Home

Download PDF
James Heaf1
Martin R. Cowie,2 Manuel Pestana3

All of the authors have been speakers for Baxter International Inc. Martin R. Cowie has received research funding and consultancy fees from Medtronic, Boston Scientific, St. Jude Medical, Inc., and Honeywell HomMed. James Heaf has received research grants, travel support, and lecture fees from Baxter International Inc. and Fresenius SE & Co. KGaA. Manuel Pestana has received research grant funding from Baxter International Inc.


Writing assistance was provided by Dr Juliet Bell of apothecom scopemedical Ltd. Martin R. Cowie’s salary is supported by the NIHR Cardiovascular Biomedical Research Unit at Royal Brompton Hospital, London, UK.


This satellite symposium was a medical education event. The event and the publication of this review article were funded by Baxter International Inc., including medical writing assistance. The views and opinions expressed are those of the authors and not necessarily those of Baxter International Inc.

EMJ Nephrol. ;3[1]:38-44. DOI/10.33590/emjnephrol/10310510.
ERA-EDTA Congress 2015, European Dialysis and Transplant Association, European Renal Association.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Meeting Summary

Dr Heaf opened the symposium by welcoming the attendees and introducing the speakers. Prof Cowie explained the concept of remote monitoring and outlined some of the tools available in cardiology, which include telephone monitoring, standalone equipment, and implanted devices. The challenges and usage of remote monitoring throughout 15 years of use in cardiology were explained, and emphasis was placed on the ability of remote monitoring devices to enable shared decision-making between the patient and healthcare professionals (HCPs) and their ability to align management strategies with patient needs. Prof Pestana then described the advantages and limitations of home-based peritoneal dialysis (PD). PD is an existing therapy that may benefit from additional patient and clinical support through telemonitoring and remote monitoring devices. Studies that assessed telemonitoring as a support for home-based PD versus centre-based haemodialysis were evaluated and the importance of shared decision-making was emphasised. The requirement for personalised decision-making tools in order to enhance medical supervision and provide more data for clinical decisions was discussed.

Please view the full content in the pdf above.

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally